Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis

Abstract The majority of disease modifying therapies for multiple sclerosis (MS) reduce inflammation, but do no't target remyelination. Development of remyelinating therapies will benefit from a method to quantify myelin kinetics in patients with MS. We labeled myelin in vivo with deuterium, an...

Full description

Saved in:
Bibliographic Details
Main Authors: Kawita M. S. Kanhai (Author), Sebastiaan C. Goulooze (Author), Jeroen van derGrond (Author), Amy C. Harms (Author), Thomas Hankemeier (Author), Ajay Verma (Author), Gersham Dent (Author), Juan Chavez (Author), Henri Meijering (Author), Geert Jan Groeneveld (Author)
Format: Book
Published: Wiley, 2022-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available